Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,247Revenue $M113Net Margin (%)-21.6Z-Score7.2
Enterprise Value $M1,219EPS $-0.3Operating Margin %-24.5F-Score5
P/E(ttm))0Cash Flow Per Share $-1.0Pre-tax Margin (%)-21.6Higher ROA y-yY
Price/Book34.110-y EBITDA Growth Rate %0Quick Ratio1.9Cash flow > EarningsY
Price/Sales10.65-y EBITDA Growth Rate %-26.6Current Ratio2.1Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-26.8Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-69.7Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M86.1ROI % (ttm)-62.0Gross Margin Increase y-yY

Gurus Latest Trades with CADX

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

CADX is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


CADX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LARUE WILLIAM RSVP, CFO, Treas, Asst Sec 2013-12-17Sell8,500$9.1253.29 view
AKER HAZEL MSVP, GC & Secretary 2013-12-16Sell13,014$8.7659.59 view
Byrd Scott A.SVP, Chief Commercial Officer 2013-12-02Sell7,812$9.1652.62 view
LARUE WILLIAM RSVP, CFO, Treas, Asst Sec 2013-11-18Sell36,000$7.391.51 view
Byrd Scott A.SVP, Chief Commercial Officer 2013-11-15Sell10,416$874.75 view
AKER HAZEL MSVP, GC & Secretary 2013-11-15Sell52,056$7.4188.66 view
AKER HAZEL MSVP, GC & Secretary 2013-07-22Sell6,507$7.8179 view
Lloyd-Smith MalcolmSVP, Reg Affairs, Qual & Clin 2013-07-22Sell14,000$7.8578.09 view
LARUE WILLIAM RSVP, CFO, Treas, Asst Sec 2013-07-17Sell9,000$7.2692.56 view
AKER HAZEL MSVP, GC & Secretary 2013-07-15Sell6,508$7.3490.46 view

Press Releases about CADX :

    Quarterly/Annual Reports about CADX:

    News about CADX:

    Articles On GuruFocus.com
    Can Malllinckrodt Keep on Crushing Expectations? Mar 19 2014 
    Cadence Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 05 2010 
    Cadence Pharmaceuticals Inc. (CADX) President, CEO Theodore R Schroeder sells 50,000 Shares Oct 04 2010 
    Cadence Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 06 2010 
    Cadence Pharmaceuticals Inc. (CADX) President, CEO Theodore R Schroeder sells 50,000 Shares Jul 01 2010 
    Cadence Pharmaceuticals Inc. (CADX) President, CEO Theodore R Schroeder sells 50,000 Shares Apr 01 2010 
    Cadence Pharmaceuticals Inc. (CADX) President, CEO Theodore R Schroeder sells 30,000 Shares Jan 04 2010 
    Cadence Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 05 2009 
    Cadence Pharmaceuticals Inc. (CADX) President, CEO Theodore R Schroeder sells 20,000 Shares Oct 19 2009 
    Cadence Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 06 2009 

    More From Other Websites
    Mallinckrodt to buy Questcor Pharma for $5.6 bn Apr 07 2014
    Gabelli liquidates stake in Cadence Mar 20 2014
    CADENCE PHARMACEUTICALS INC Files SEC form 8-K, Termination of a Material Definitive Agreement,... Mar 19 2014
    Mallinckrodt plc Completes $1.4 Billion Acquisition of Cadence Pharmaceuticals, Inc. Mar 19 2014
    CADENCE PHARMACEUTICALS INC Financials Mar 06 2014
    Recro Pharma IPO Could Be More Painful Than Expected Mar 05 2014
    Wider-Than-Expected Q4 Loss at Cadence Pharma Mar 04 2014
    Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results Feb 28 2014
    CADENCE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Feb 28 2014
    Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results Feb 28 2014
    The Zacks Analyst Blog Highlights: Regeneron, Gilead, Medicines Co., AbbVie and Cadence Feb 20 2014
    Lifshitz & Miller Law Firm Announces Investigation of Cadence Pharmaceuticals, Inc., Chindex... Feb 19 2014
    SHAREHOLDER DEADLINE: Law Office of Brodsky & Smith, LLC Announces Investigation of Cadence... Feb 17 2014
    CADENCE PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of... Feb 14 2014
    SHAREHOLDER DEADLINE: Law Office of Brodsky & Smith, LLC Announces Investigation of Cadence... Feb 14 2014
    INVESTOR ALERT: LEVI & KORSINSKY, LLP Announces Investigation of CADENCE PHARMACEUTICALS INC. and... Feb 13 2014
    Cadence: What To Do With The Proceeds And A Post Mortem On A Successful Investment Feb 13 2014
    CADENCE INVESTOR ALERT: Faruqi & Faruqi, LLP is Investigating Cadence Pharmaceuticals, Inc. (CADX)... Feb 13 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK